Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine

Vaccine

Volumn 21, Issue 17-18, 2003, Pages 2015-2021

  Olin, Patrick ^a   Gustafsson, Lennart ^a   Barreto, Luis ^b   Hessel, Luc ^c   Mast, T Christopher ^d   Van Rie, Annelies ^c,g   Bogaerts, Hugues ^e   Storsaeter, Jann ^f  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b Aventis Pasteur Ltd   (Canada)

^c SANOFI PASTEUR   (France)

^d MERCK RESEARCH LABORATORIES   (United States)

^e GSK   (Belgium)

^f GLAXOSMITHKLINE   (United Kingdom)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Acellular vaccines; Incidence; Pertussis

Indexed keywords

ACELLULAR VACCINE; PERTUSSIS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BORDETELLA PERTUSSIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FOLLOW UP; HEALTH SURVEY; HUMAN; IMMUNITY; INFANT; NEWBORN; PERTUSSIS; PRIORITY JOURNAL; SWEDEN; VACCINATION;

EID: 0037449078     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00777-6     Document Type: Article

References (17)

1. Hewlett EL, Cherry JD. New and improved vaccines against pertussis. In: Levine MM, Woodrow GC, Kaper JB, Cobon GS, editors. New generation vaccines, second edition. New York: Marcel-Decker; 1997. p. 387-416.
2. Cherry J.D., Olin P. The science and fiction of pertussis vaccines. Commentary. Pediatrics. 104:1999;1381-1384.
3. Edwards KM, Decker MD, Mortimer EA, Pertussis vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines, third edition. Philadelphia: WB Saunders; 1999. pp 293-344.
4. Taranger J., Trollfors B., Bergfors E., Knutsson N., Sundh V., Lagergård T.et al. Mass vaccination of children with pertussis toxoid - decreased incidence in both vaccinated and nonvaccinated persons. Clin. Infect. Dis. 33:2001;1004-1009.
5. Salmaso S., Mastrantonio P., Tozzi A.E., Stefanelli P., Anemona A., Ciofi degli Atti M.L.et al. Sustained efficacy during first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics. 108(5):2001;e81-95.
6. Lugauer S., Heininger U., Cherry J.D., Stehr S. Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell component vaccine. Eur. J. Pediatr. 161:2002;142-146.
7. Wassilak SGF, Fine P. Session IV. Rapporteurs' summary. In: Brown F, Greco D, Mastrantonio P, Salmaso S, Wassilak S, editors. Pertussis vaccine trials. Karger: Basel. Dev Biol Stand 1997;89:187-93.
8. Olin P., Rasmussen F., Gustafsson L., Hallander H.O., Heijbel H. For the Ad Hoc Group for the study of pertussis vaccines: randomised trial of two-component. Lancet. 350:1997;1569-1577.
9. Romanus V., Jonsell R., Bergquist S.-O. Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr. Infect. Dis. J. 6:1987;364-371.
10. Olin P., Hallander H.O. Marked decline in pertussis followed reintroduction of pertussis vaccination in Sweden. EuroSurveillance. 4:1999;128-129.
11. Trollfors B., Taranger J., Lagergård T., Lind I., Sundh V., Zackrisson G.et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N. Engl. J. Med. 333:1995;1045-1050.
12. Taranger J., Trollfors B., Lagergård T., Lind L., Sundh V., Zackrisson G.et al. Unchanged efficacy of a pertussis toxoid vaccine throughout the 2 years after the third vaccination of infants. Pediatr. Infect. Dis. J. 16:1997;180-184.
13. WHO meeting on case definition of pertussis. Geneva, 10-11 January 1991, vol. 1. Geneva: WHO; MIN/EPI/PET/91. p. 4-5.
14. Yih W.K., Lett S.M., des Vignes F.N., Garrison K.M., Sipe P.L., Marchant C.D. The increasing incidence of pertussis in Massachusetts' adolescents and adults, 1989-1998. J. Infect. Dis. 182:2000;1409-1416.
15. Hethcote H.W. Simulations of pertussis epidemiology in the United States: effect of adult booster vaccination. Math. Biosci. 158:1999;47-73.
16. van Boven M., de Melker H.E., Schellekens J.F., Kretzschmar M. Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in the Netherlands. Math. Biosci. 164:2000;161-182.
17. Olin P. Vaccination programmes out of pace with vaccine development B a call for national vaccination registers. Invited commentary. Acta Paediatr. 88:1999;800-802.